Feb. 1 (Bloomberg) -- Valeant Pharmaceuticals International, Inc. will acquire privately owned PharmaSwiss SA for 350 million euros ($480 million), Valeant said in a PRNewswire statement today. HBM BioVentures AG said it will book a 41.9 million euro profit from the sale.
WHAT TO WATCH: *SNB Vice President Thomas Jordan speaks in Vienna (5:30 p.m.) *The Federal Statistics Office reports retail sales data for December (9:15 a.m. Zurich time) *Credit Suisse Group AG reports the Swiss purchasing managers’ index for January (9:30 a.m.)
EQUITIES: *Luzerner Kantonalbank Reports Full-Year Profit of 169.4 Million Swiss Francs ($180 Million) *Tornos Has Full-Year Sales of 160.1 Million Francs *Valartis Appoints Hermann, Kast and Reptsis *Partners Group Completes Investment in Saehwa *BKW FMB Acquires Allevard Hydroelectric Power Plant Group
MARKETS: *The SMI lost 0.8 percent to close at 6,479.15 *The SPI fell 0.7 percent to close at 5,814.95 *Euro -- Franc at 1.2919 at 7:26 a.m. Zurich time
To contact the reporter on this story: Paul Verschuur at email@example.com
To contact the editor responsible for this story: Angela Cullen at firstname.lastname@example.org